People taking methotrexate for a variety of conditions have been warned by the NHS that a number of symptoms and side effects ...

Methotrexate is widely prescribed for arthritis, psoriasis, and certain cancers. Here’s what patients need to know about ...

The Belgian biotech is still on the hunt for partners after reporting that its drug succeeded against an inflammatory skin ...

In guidelines issued by the American Society of Clinical Oncology and published online Dec. 11 in the Journal of Clinical ...

Overall, the reviewers wrote, most IBD therapies “appear safe and effective when used in chronic kidney disease, including on ...

Aldeyra Therapeutics announces PDUFA extension date by US FDA for NDA of Reproxalap to treat dry eye disease: Lexington, Massachusetts Thursday, December 18, 2025, 16:00 Hrs [IST] ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Learn more about whether Halozyme Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The results of the Precision-T Phase 3 study of investigational allogeneic T-cell immunotherapy, Orca-T, were published in the journal Blood.

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active ...